| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel ACTA1 mutation resulting in a severe congenital myopathy with nemaline bodies, intranuclear rods and type I fibre predominance
|
Ravenscroft, Gianina
|
|
2011
|
21 |
1 |
p. 31-36
6 p.
|
artikel
|
| 2 |
Charcot-Marie-Tooth 1A patients with low level of impairment have a higher energy cost of walking than healthy individuals
|
Menotti, Federica
|
|
2011
|
21 |
1 |
p. 52-57
6 p.
|
artikel
|
| 3 |
Choosing the right clinical outcome measure: From the patient to the statistician and back
|
Mercuri, Eugenio
|
|
2011
|
21 |
1 |
p. 16-19
4 p.
|
artikel
|
| 4 |
Commentary from the Editor
|
Dubowitz, Victor
|
|
2011
|
21 |
1 |
p. 1-2
2 p.
|
artikel
|
| 5 |
Current concerns in the therapy of neuromuscular disorders
|
Dubowitz, Victor
|
|
2011
|
21 |
1 |
p. 3-
1 p.
|
artikel
|
| 6 |
Developing standard procedures for pre-clinical efficacy studies in mouse models of spinal muscular atrophy
|
Willmann, Raffaella
|
|
2011
|
21 |
1 |
p. 74-77
4 p.
|
artikel
|
| 7 |
Developmental defects and neuromuscular alterations due to mitofusin 2 gene (MFN2) silencing in zebrafish: a new model for Charcot-Marie-Tooth type 2A neuropathy
|
Vettori, Andrea
|
|
2011
|
21 |
1 |
p. 58-67
10 p.
|
artikel
|
| 8 |
Duchenne muscular dystrophy: Survival by cardio-respiratory interventions
|
Ishikawa, Yuka
|
|
2011
|
21 |
1 |
p. 47-51
5 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2011
|
21 |
1 |
p. IFC-
1 p.
|
artikel
|
| 10 |
EMNC
|
|
|
2011
|
21 |
1 |
p. I-
1 p.
|
artikel
|
| 11 |
Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: Less severe mutations predominate in patients with a non-Walker-Warburg phenotype
|
Yis, Uluc
|
|
2011
|
21 |
1 |
p. 20-30
11 p.
|
artikel
|
| 12 |
Infantile onset myofibrillar myopathy due to recessive CRYAB mutations
|
Forrest, Katharine M.L.
|
|
2011
|
21 |
1 |
p. 37-40
4 p.
|
artikel
|
| 13 |
Magnetic resonance imaging assessment of cardiac dysfunction in δ-sarcoglycan null mice
|
Wansapura, Janaka P.
|
|
2011
|
21 |
1 |
p. 68-73
6 p.
|
artikel
|
| 14 |
Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with Limb Girdle Muscular Dystrophy 2I
|
Stensland, Eva
|
|
2011
|
21 |
1 |
p. 41-46
6 p.
|
artikel
|
| 15 |
Referees consulted 2010
|
|
|
2011
|
21 |
1 |
p. 79-80
2 p.
|
artikel
|
| 16 |
Stem cells to treat muscular dystrophies – Where are we?
|
Meng, Jinhong
|
|
2011
|
21 |
1 |
p. 4-12
9 p.
|
artikel
|
| 17 |
Sunnier days
|
Sibley, Martyn
|
|
2011
|
21 |
1 |
p. 78-
1 p.
|
artikel
|
| 18 |
The risks of therapeutic misconception and individual patient (n =1) “trials” in rare diseases such as Duchenne dystrophy
|
Aartsma-Rus, Annemieke
|
|
2011
|
21 |
1 |
p. 13-15
3 p.
|
artikel
|
| 19 |
WMS 2011
|
|
|
2011
|
21 |
1 |
p. II-
1 p.
|
artikel
|
| 20 |
WMS News
|
|
|
2011
|
21 |
1 |
p. IV-V
nvt p.
|
artikel
|
| 21 |
WMS online application form
|
|
|
2011
|
21 |
1 |
p. III-
1 p.
|
artikel
|
Tijdschrift beschrijving